Login
- Document type:
- Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't; Letter
- Author(s):
- Elter, T; James, R; Busch, R; Winkler, D; Ritgen, M; Böttcher, S; Kahl, C; Gassmann, W; Stauch, M; Hasan, I; Staib, P; Fischer, K; Fink, AM; Bahlo, J; Bühler, A; Döhner, H; Wendtner, CM; Stilgenbauer, S; Engert, A; Hallek, M
- Title:
- Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia.
- Journal title abbreviation:
- Leukemia
- Year:
- 2012
- Journal volume:
- 26
- Journal issue:
- 12
- Pages contribution:
- 2549-52
- Language:
- eng
- Fulltext / DOI:
- doi:10.1038/leu.2012.129
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/22584787
- Print-ISSN:
- 0887-6924
- TUM Institution:
- Institut für Medizinische Statistik und Epidemiologie
BibTeX